Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PanKbase Integrated Single-Cell Map: A Comprehensive Atlas of Human Pancreatic Islets.

bioRxiv : the preprint server for biology·2026
Same author

Liver Metastases License Neutrophils through IL1 to Potentiate Cancer Progression.

Cancer immunology research·2025
Same author

Engineered immunological niche directs therapeutic development in models of progressive multiple sclerosis.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancreatic Cancer.

Molecular cancer therapeutics·2024
Same author

SLC4A11 mediates ammonia import and promotes cancer stemness in hepatocellular carcinoma.

JCI insight·2024
Same author

Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancer.

JCI insight·2024

Related Experiment Video

Updated: Mar 26, 2026

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

25.1K

Targeting CXCL13 During Neuroinflammation.

Amanda K Huber1, David N Irani1

  • 1Department of Neurology, University of Michigan Medical School, Ann Arbor, MI, USA.

Advances in Neuroimmune Biology
|February 9, 2016
PubMed
Summary

Chemokine CXCL13, crucial for lymphoid organs, also drives central nervous system (CNS) inflammation. Targeting CXCL13 or its receptor offers a potential therapeutic strategy for CNS disorders.

Keywords:
CXCL13CXCR5lymphoid chemokinesmultiple sclerosisneuroborreliosispost-stroke dementiaprimary central nervous system lymphoma

More Related Videos

Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research
04:43

Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research

Published on: June 16, 2023

1.7K
Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact
11:29

Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact

Published on: July 17, 2016

29.0K

Related Experiment Videos

Last Updated: Mar 26, 2026

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

25.1K
Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research
04:43

Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research

Published on: June 16, 2023

1.7K
Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact
11:29

Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact

Published on: July 17, 2016

29.0K

Area of Science:

  • Neuroimmunology
  • Molecular Biology

Background:

  • Chemokine C-X-C motif ligand 13 (CXCL13) is essential for lymphocyte and antigen-presenting cell organization in lymphoid organs.
  • CXCL13 is increasingly recognized for its role in central nervous system (CNS) inflammation.

Purpose of the Study:

  • To review the contribution of CXCL13 to the pathogenesis of CNS disorders.
  • To evaluate CXCL13 as a potential therapeutic target in CNS diseases.

Main Methods:

  • Literature review of studies involving experimental animals and human subjects.
  • Analysis of the role of CXCL13 and its receptor in CNS inflammation.

Main Results:

  • CXCL13 plays a role in the pathogenesis of various CNS disorders, including neoplastic, infectious, and autoimmune conditions.
  • Evidence suggests that blocking CXCL13 or its receptor may benefit patients with certain CNS diseases.

Conclusions:

  • CXCL13 is implicated in CNS inflammation and disease pathogenesis.
  • Therapeutic strategies targeting CXCL13, such as monoclonal antibodies or small molecule inhibitors, show promise for treating CNS disorders.